Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Maze Therapeutics, Inc. | 350,987 | reported | 26 May 2026 | tx 8+325,000−34,502 |
| Corvus Pharmaceuticals, Inc. | 200,000 | reported | 08 Jun 2016 | tx 1+200,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 22 May 2026 | SALE | Maze Therapeutics, Inc. | 4,504 | 26.00 USD | 10b5-1 |
| 22 May 2026 | SALE | Maze Therapeutics, Inc. | 2,478 | 26.00 USD | 10b5-1 |
| 26 May 2026 | SALE | Maze Therapeutics, Inc. | 25,582 | 26.02 USD | 10b5-1 |
| 15 May 2026 | SALE | Maze Therapeutics, Inc. | 1,822 | 26.00 USD | 10b5-1 |
| 15 May 2026 | SALE | Maze Therapeutics, Inc. | 116 | 26.00 USD | 10b5-1 |
| 02 Mar 2026 | GRANT_AWARD | Maze Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Maze Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 22 Sept 2025 | GRANT_AWARD | Maze Therapeutics, Inc. | 100,000 | 0.00 USD | deriv |
| 08 Jun 2016 | GRANT_AWARD | Corvus Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |